Factors
Stocks
Valuation
Portfolio
Visualizations
More
Research date: November 1, 2026
Closing price before research date: $110.91
Current price: $110.91

AGCO Corporation (NYSE: AGCO) — North America Improves as Cash Tests Recovery

Published: 2026-11-01 · Verdict: Hold · Entry price: $90 · Research confidence: High (85%)

Executive conclusion

Analyst Take

HOLD at the October 30, 2026 close of $110.91. A preferred entry around $90 offers better compensation for the uncertain recovery; a measured recovery supports approximately $100–110 of present value. These are analyst judgments, not company forecasts. No twelve-month price target is assigned. AGCO retains valuable machinery brands, dealer relationships and aftermarket demand, but another operating-guidance reduction, a large fourth-quarter cash requirement and unproven acquisition returns prevent a stronger conclusion. The assessment incorporates the October 29 results and call. S2 S3 [S13]

The most encouraging development is North America. Third-quarter revenue increased 34.8%, and segment operating income improved from a $42.0 million loss to a $13.8 million profit. Subtracting the $13 million tariff refund leaves approximately $0.8 million: essentially break-even, with a substantial improvement beyond the recovery. However, the nine-month result is less reassuring. The reported $61.7 million loss includes $35 million of refunds; excluding them produces a $96.7 million loss, slightly worse than the previous year’s $91.4 million loss. One strong quarter has changed the trajectory without establishing that the annual business earns an adequate return. [S2][S3][S4]

Europe/Middle East, historically the earnings anchor, weakened as North America improved. Third-quarter sales declined 19.1%, operating income fell $115.1 million, and margin declined to 10.5%. The region still earned a 14.2% margin through September, so the franchise has not been disproved. Nevertheless, its deterioration matters more to consolidated earnings than a small positive North American quarter. The most useful framing is a regional handoff with uncertain timing, rather than a synchronized global recovery. [S2][S3]

Management reduced the sales outlook to $9.8–10.0 billion and adjusted operating margin to approximately 7%, versus $10.1–10.2 billion and 7.5% in July. Adjusted EPS is now approximately $5.50, the bottom of July’s $5.50–5.75 range. The limited EPS change understates the operating downgrade because fewer shares, financing economics and recognized recoveries support per-share results. At approximately 20 times guided adjusted EPS, investors are paying for improvement beyond the current earnings level. The base scenario reaches about $11.22 of EPS in 2029, but discounting that future outcome produces approximately $104 per share, including ordinary dividends. [S3][S5]

The variant perception is that AGCO’s aftermarket and distribution assets are more defensible than a simple machinery-cycle label suggests, while its technology economics are less established than the strategic narrative implies. Replacement parts generated $1.873 billion in 2025 and remained resilient in the latest quarter. PTx can sell upgrades into mixed fleets, including customers who never buy an AGCO tractor. Those are real commercial opportunities. They do not establish recurring software economics, a data network effect, or an acceptable return on the original acquisition consideration. The early PTx impairment and limited standalone profitability disclosure remain central qualifications. [S1][S7][S19]

The strongest counter-case is that the stock will anticipate recovery before annual profits and retail units confirm it. European dealer inventories are below target, selected North American early orders are up by high teens to approximately 20%, and management identifies about $40 million of savings carryover into 2027. Production moving toward retail could improve absorption without a new agricultural boom. That mechanism is credible. Its scale is uncertain: early orders cover only 20–25% of North American sales, management warns against extending seasonal-product growth to tractors, and Latin America may continue underproducing during 2027. [S4]

Investment conviction is medium. Evidence quality is high for reported financials, transaction consideration, debt, share retirement and the regional profit bridge. Confidence is lower in recovery timing, economic PTx returns, normalized taxes and terminal valuation. Management’s recovery expectations are useful hypotheses, not independent confirmation. The factor model contributes a dated risk diagnostic and supplies no evidence that sellers are exhausted or the shares are uncrowded.

The decision sequence is concrete. First, test the roughly $670–770 million fourth-quarter free-cash-flow requirement implied by retained conversion guidance. Second, require North American profit without recoveries and without increasing physical channel inventory. Third, assess Europe’s seasonal rebound through pricing, orders and cash rather than margin alone. Fourth, require PTx growth to translate into operating contribution. Strong cash conversion, durable regional profits and a credible technology return bridge would improve the call. Another material operating downgrade, distributions accompanied by rising leverage and weak operating cash, or further impairment accompanied by weaker commercial assumptions would worsen it. The price offers recovery exposure, but only a limited cushion against delay. [S2][S4]

Changes since 2026-08-22

The shares rose 3.8% from the August baseline of $106.81 to $110.91. The earlier sub-$100 accumulation threshold was reached intraday on October 29, when the low was $98.68. No post-baseline closing price in the reviewed series was below $100. A threshold being touched does not validate the earlier earnings assumptions or establish an achievable purchase without execution details. [S13]

Several prior propositions survive: parts cushion equipment cyclicality, Europe supplies most segment profit, tariff recoveries need separate treatment, and North America has meaningful operating leverage. The literal positive-quarter test for North America was met, although profit excluding the refund was negligible. Another operating-guidance reduction and deteriorating Latin American inventory coverage activate the earlier cautionary signals. Neither proves that recovery has moved beyond 2027; both weaken confidence in its breadth. [S2][S4]

Material baseline errors are corrected. Parts revenue and PTx purchase consideration were disclosed. PTx North America’s October 2025 goodwill headroom was explicitly 16%. The minority earnings allocation was not the balance-sheet minority claim, which was $299.2 million at December 2025. AGCO sold its North American finance-JV stakes in April 2026, TAFE remained an AGCO shareholder, and Indira Agarwal became CFO effective August 1. The regular dividend had already increased to $0.30 quarterly. These were not unresolved disclosure gaps. [S1][S2][S18]

Two interpretive shortcuts are withdrawn. European geographic margin is not Fendt’s standalone margin, and a revenue decline is not an identical volume decline. Portfolio changes, currency, price, mix and geographic cost allocation matter. A price high coinciding with a filing date cannot establish that investors misunderstood earnings. Likewise, a near-zero momentum coefficient says nothing definitive about ownership or crowding. The earlier normalized valuation also omitted the time required to earn the projected profits. These corrections narrow the conclusion while preserving a testable recovery thesis. [S1][S2][S23]

Stock Price Action — Five-Year Event Map

The consistent unadjusted daily series runs from November 1, 2021 through October 30, 2026. Its highest close was $148.65 on March 28, 2022; its lowest was $75.77 on April 8, 2025. The current $110.91 is 25.4% below that five-year closing high. The latest 52-week intraday range was $98.22–$143.78, placing the current price 12.9% above the low and 22.9% below the high. Closing and intraday observations are identified separately. [S13]

Period Observed price fact Interpretation and evidence
November 2021–March 2022 $123.93 to the $148.65 closing high Strong farm economics and equipment demand supported the upcycle; pricing, inflation and supply constraints also affected results. [S9][S10]
2023–2024 The shares retreated as the operating cycle reversed Lower demand, production cuts and portfolio changes provide an economic explanation; no single factor explains every session. [S1][S7]
April 2025 Lowest reviewed close of $75.77 on April 8 The tariff shock and broad risk reduction are plausible drivers; the price alone does not establish company-specific distress. [S13]
February 2026 A $140.49 close on February 13 marked the latest 52-week closing high Recovery expectations, portfolio simplification and capital returns were relevant; filing-date coincidence does not prove an earnings misunderstanding. [S1][S25]
July 29–30, 2026 $116.17 to $107.13, down 7.8% The Q2 outlook reduction is a direct company-event explanation, alongside market influences. [S5]
August 18–21, 2026 $98.45 to $106.81, up 8.5% Deere’s August 20 results and cycle-bottom commentary plausibly supported the agricultural-equipment cohort. [S16]
October 28–30, 2026 $102.16 to $110.91, up 8.6% North American improvement and orders plausibly outweighed the reduced outlook in investors’ assessment; precise attribution remains inference. [S3][S4]

All price observations are from Company Financials. Special dividends mean this raw price series is not a total-return series. The prior adjusted-price presentation cannot be mixed with these observations, and historical operating comparisons also require attention to disposals and acquisitions. [S13]

Verdict: The latest rally demonstrates that shares can anticipate an earnings turn while guidance falls. It provides no independent proof that European demand, Brazilian credit or consolidated economic returns have bottomed.

Business Overview

AGCO designs, manufactures and distributes agricultural machinery, precision technology and replacement parts. Its principal brands are Fendt, Massey Ferguson, Valtra and PTx. Approximately 2,800 independent dealers and distributors reach customers in about 140 countries. Deere and CNH are the two principal worldwide competitors identified in the annual filing. AGCO lacks their construction businesses, making agriculture the dominant source of operating exposure. [S1]

The customer buys field capacity and reliability during narrow working windows. Tractor horsepower, fuel efficiency, implement compatibility, service response and resale value all contribute to ownership economics. Precision equipment adds a separate proposition: reducing overlap, inputs, labor or missed work on an existing machine. A premium invoice can therefore be rational for a farmer if expected productivity and uptime justify it. The manufacturer’s investment case requires a further step: capturing sufficient profit after engineering, distribution, warranty and capital costs.

The business and its economic drivers are readily understandable: farm cash profitability influences replacement, dealer inventories separate wholesale shipments from retail demand, and factory utilization amplifies changes in shipments into larger changes in operating profit. The accounting becomes more complicated because technology, aftermarket, financing arrangements, acquisitions and taxes cross those operating relationships. Understanding the customer does not make adjusted EPS self-explanatory.

Revenue composition and stability

Product grouping 2025 revenue Share Economic character
Tractors $6,693.0M 66.4% Large, often financed and deferrable replacement purchases
Replacement parts $1,873.3M 18.6% Installed-base maintenance and utilization
Combines, application equipment and other machinery $1,514.4M 15.0% Seasonal machinery and technology-bearing equipment
Remaining grain/protein products $1.3M Negligible Residual following disposal
Total $10,082.0M 100% Predominantly transactional

These audited product categories reconcile to consolidated revenue. PTx sales overlap the product and geographic classifications; adding PTx to the table would double count activity. Its commercial channels should be analyzed separately without pretending it is a fifth additive revenue category. [S1] (Note 24)

Revenue is predominantly transactional, with a measurable aftermarket cushion rather than a contractual annuity. Parts increased from $1.828 billion in 2024 to $1.873 billion in 2025 while total sales declined. Through September 2026 they contributed $1.469 billion, approximately 20.4% of revenue. Q3 parts revenue was about $506 million, up just over 1%, against an 8.6% consolidated decline. That demonstrates relative resilience, not immunity to farm activity. [S1][S2][S4]

Deferred machine replacement can support maintenance spending, but parts demand still depends on hours worked, equipment age, repair economics and dealer stocks. Farmers can postpone nonessential repairs, use alternative suppliers or reduce utilization. Dealers can reduce parts inventory independently of end-customer consumption. The installed base softens the cycle; it does not remove it.

Contract liabilities of $386.1 million at December 2025 included extended warranties, maintenance and precision services. Remaining performance obligations were primarily associated with extended warranties. These balances demonstrate prepaid lifecycle relationships, but cannot be called software annual recurring revenue. Warranty consideration comes with future service costs, and some technology revenue remains hardware or usage based. [S1] (Note 24)

Geographic economics and reporting boundaries

Region, 2025 definitions Sales Segment operating income Margin
Europe/Middle East $6,736.7M $1,006.8M 14.9%
North America $1,665.5M $(112.0)M (6.7)%
South America $1,115.6M $51.4M 4.6%
Asia/Pacific/Africa $564.2M $27.8M 4.9%

Europe supplied 66.8% of revenue. Germany and France alone contributed approximately $2.97 billion, demonstrating concentration without reducing the region to one country or brand. The income figures exclude material corporate and other reconciling items. Mexico moved from North America into renamed Latin America in January 2026; quarterly comparatives were recast. G&P was also removed from historical geographic segments and presented separately in relevant annual comparisons. [S1][S2]

These boundaries matter commercially and analytically. European production supplies other regions, brands differ in positioning, and engineering and selling expenses are assigned partly where incurred. Geographic margins cannot isolate Fendt profitability or the causal effect of dealer density. The profitable European system is an asset, but not a separable security with a disclosed independent cash-flow statement.

Dealers, financing and economic assets

Independent dealers invest in technicians, facilities, spare parts, local knowledge and used-equipment merchandising. That capital extends AGCO’s customer reach without appearing as owned distribution assets. The benefit is accompanied by dependence: weak dealer profitability can undermine service, trade-in capacity and willingness to stock equipment before AGCO records an obvious loss.

Financing affects both affordability and channel liquidity. AGCO historically held 49% interests in Rabobank finance ventures. In April 2026 it sold its U.S. and Canadian stakes for $188.4 million and retained financing access through commercial framework agreements. Other affiliate investments remain. AGCO therefore has less consolidated finance debt to disentangle than Deere or CNH, but continues to depend on funding availability, receivable-sale programs and selected guarantees. [S2] (Notes 2 and 15; MD&A)

Economically valuable assets not fully captured in book value include dealer relationships, installed-machine knowledge, service capability, internally developed know-how and reputation. Their value must appear in retention, pricing, parts capture or returns. Some acquired brands and technology are already recognized, so adding a general intangible premium risks double counting.

AGCO is a Delaware corporation issuing NYSE-listed common stock, not an ADR, MLP or partnership security. Ordinary ownership does not create the partnership K-1 structure. The security represents residual ownership after funded debt, other obligations and redeemable minority claims, rather than an interest directly in the financing affiliates. [S1][S2]

Verdict: The machinery, aftermarket and technology model is coherent and understandable. Parts and service provide a financial cushion, but the majority of sales remain financed replacement purchases, with significant European concentration and dealer dependence.

Industry Dynamics

Agricultural equipment combines durable entry barriers with discretionary replacement timing. Farmers need working machinery over a machine’s lifetime, but can defer an individual purchase for several seasons. Manufacturers must maintain engineering, compliance, parts support and distribution while volumes fluctuate. That mismatch explains why an industry with meaningful barriers can still deliver volatile shareholder returns.

The market is international and mature in machinery units, with growth opportunities in productivity, precision content, aftermarket capture and mechanization. A precise, comparable global market-size estimate is not established by the reviewed primary evidence. Commercial estimates often mix tractors, implements, software, construction and services. For AGCO, regional retail units, installed fleets and technology penetration are more useful than an unverified global revenue forecast. [S1][S3]

Farmer economics and the replacement decision

Equipment affordability depends on expected crop and livestock receipts less inputs, labor, rent, financing and other costs. Land appreciation can support collateral while operating cash confidence remains weak. A farmer also needs a workable trade-in: lower used-equipment prices increase the cash gap to a new machine, while dealers become reluctant to accept another used unit.

USDA’s September forecast puts calendar-2026 net farm income at $158.4 billion, down 2.6% nominally and 5.5% after inflation. Net cash farm income is forecast at $176.4 billion, up only 0.4% nominally. Direct government payments are estimated at $47.4 billion. These forecasts revise the prior baseline and describe aggregate farming, not specifically AGCO’s customers or European and Brazilian conditions. [S14]

Support payments are economically relevant. They can improve debt service and purchase capacity, contrary to the earlier categorical claim that transfers do not fund replacement. Their equipment effect depends on who receives them, timing, confidence and expectations of persistence. Aggregate support can coexist with poor row-crop margins or cautious capital spending. A durable demand turn requires more than a high nominal farm-income headline.

External retail data remain weak. AEM reported September U.S. tractor sales down 16.4% and combines down 10.9%. AGCO’s estimates through September show North American tractors excluding compacts down 9%, Brazilian tractors down 17%, and Western European tractors down 1%; Europe’s third quarter alone was down 9%. Different definitions and periods prevent aggregation into one global index. The common direction contradicts a broad realized recovery. [S15][S3]

Competitors and profit pools

Deere and CNH are the principal full-line worldwide rivals. Regional and specialist competition also matters, including CLAAS in European harvesting and Kubota in smaller machinery. Competition varies by product, farm structure and geography; an aggregate corporate ranking cannot establish who has the best local service economics.

The profit pool is visibly uneven. Deere’s latest Production & Precision Agriculture quarter earned a 13.2% operating margin and Small Agriculture & Turf 18.4%. CNH Agriculture earned a 5.2% adjusted EBIT margin in Q2. AGCO’s Q3 consolidated adjusted margin was 6.1%, with EME at 10.5% before corporate reconciliation. CNH also reported financial-services past dues of 4.4%, versus 3.9% a year earlier, with deterioration in South America. That is a peer credit observation, not a measure of AGCO customers’ defaults; it independently supports scrutiny of financing conditions in the region. [S17]

Different periods, product mixes and accounting definitions prevent a precise league table. They nevertheless show that barriers protect the industry’s existence more reliably than each competitor’s return. [S16][S17][S3]

Entry requires more than assembling a tractor. Professional customers need reliable drivetrains, emissions compliance, compatible implements, agronomic integration, technicians, parts logistics, finance and acceptable resale values. A functional machine can enter faster than a credible local support system. Specialists can still contest individual implements, sensors, retrofit functions or compact categories without funding a full global product line.

Low-cost foreign production is a greater threat in simpler, price-sensitive equipment than in service-intensive high-horsepower systems. Compliance and uptime requirements slow displacement, but do not permanently exclude capable suppliers. AGCO itself sources selected machines and components externally. Outsourcing can improve flexibility and capital efficiency; it does not by itself prove either a manufacturing disadvantage or a cost moat. [S1]

Competitive intensity, regulation and supply

Competition is becoming more technological and regionally more promotional, while manufacturers continue restraining machinery output. Positive aggregate pricing does not establish universal discipline. AGCO disclosed negative pricing in Latin America and targeted discounts on aged non-tractor inventory. Stable consolidated gross margins also reflect mix, parts, currencies and portfolio changes. [S2][S4]

Technology broadens the competitive boundary. Mixed-fleet compatibility enables a supplier to win an upgrade without winning the original machine purchase, expanding its addressable customers. It also lets rivals contest individual tasks. Openness is a distribution advantage only when installation, performance, support and monetization remain attractive. The strategy can reduce customer captivity while creating a new service relationship.

Regulation raises costs and entry barriers simultaneously. Emissions rules require sustained development; dealer laws can restrict termination and require inventory repurchases; government programs affect customer income and credit. Tariffs influence imported components, finished machinery and agricultural export economics. Recovering a past tariff payment does not establish that future imports will face a lower burden. [S1][S2]

The supply-side capital cycle is mixed. Q3 production hours fell about 19%, and management expects full-year hours down roughly 5%. Underproduction sacrifices factory absorption while reducing channel risk. If retail stabilizes, output can move toward retail and improve profit before end demand grows. However, hours measure utilization, not permanent capacity removal, and an impairment removes accounting value rather than tractor supply. [S4]

Capital is also flowing into technology, not simply leaving machinery. PTx purchase consideration, ongoing research and dealer development commit resources to a contested profit pool. Factory discipline can coexist with weak acquisition returns. The useful capital-cycle distinction is between machinery capacity, channel inventory and technology investment; improvement in one does not settle the others.

Verdict: Entry barriers, aftermarket demand and production discipline support the prospect of a profitable recovery. Weak retail, regional discounting and continued technology investment prevent assuming that supply restraint guarantees either its timing or superior returns for AGCO.

Competitive Position

AGCO’s competitive position rests on differentiated machinery, local service, installed equipment and technology distribution. Each has a financial test. Differentiation should support price or share without excessive warranty costs. Service should improve retention and parts capture. Technology should produce profitable sales beyond AGCO’s own machine base. None is established simply by describing the company as premium or innovative.

Brand economics and regional advantage

Brands matter economically when customers accept price premiums, retain equipment, buy parts and preserve resale value. Fendt, Valtra and Massey Ferguson participate in different customer and geographic segments. The strongest historical evidence is EME’s $1.007 billion of 2025 segment profit and management’s attribution of its increase partly to positive net pricing. The region’s margin remained 14.9% despite lower sales and production volumes. [S1]

However, EME is not Fendt alone. It includes several brands, parts and precision products, with costs allocated partly by where incurred. The third-quarter margin decline from approximately 15.6% to 10.5% demonstrates substantial exposure to absorption. It does not independently prove pricing deterioration, because management attributes the decline chiefly to volumes and production. The defensible conclusion is a differentiated franchise with fixed-cost sensitivity, rather than a permanent 15% regional annuity. [S2]

Local service provides an understandable barrier. Dealers need enough machines nearby to justify specialist technicians and stocked parts; farmers value rapid repairs during planting and harvesting. That can support a reinforcing relationship between local installed base, service economics and customer retention. Without the mechanism, one would expect weaker parts capture, less premium pricing, poorer resale values or greater share volatility. Public data support parts resilience and selected pricing outcomes, but do not isolate dealer density as the cause of every regional margin difference.

Competition is based on total ownership economics: performance, uptime, service, finance, warranty, compatibility, residual value and purchase price. A cheaper machine may be more expensive over its life if downtime or resale costs are higher. The reverse is equally important: a premium machine does not justify its price when actual productivity or service falls short.

Customer switching costs include operator training, technician familiarity, implements, parts inventories, data workflows, financing and the trade-in relationship. They vary by farm and machine. Mixed fleets demonstrate that switching is possible, while interoperability can reduce some data friction. Retention earned through good performance is valuable but remains contestable; it should not be confused with permanent customer captivity.

North America’s more balanced evidence

The structural-loss argument has weakened. Q3 operating profit improved $55.8 million on $125.4 million of additional sales. Removing the $13 million refund leaves $42.8 million of improvement, or approximately 34% of the revenue increase. This is a calculated incremental margin, not an isolated volume coefficient: price, mix, costs and production all changed. Still, the improvement cannot be dismissed as entirely a refund. [S2][S3]

Historical evidence also argues against saying the region can never earn money. On the annual filing’s recast basis excluding divested G&P, North America generated $398.1 million of segment income on $3.138 billion of 2023 sales, before falling to $84.0 million in 2024 and a $112.0 million loss in 2025. PTx changed the perimeter during that interval, so the series is not a clean same-business experiment. It nevertheless demonstrates prior profitability and the magnitude of the shipment contraction. [S1] (Note 25)

The remaining test is adequate annual return. Management now estimates break-even revenue of $2.2–2.3 billion in the tariff environment, versus regional sales approaching approximately $2 billion in 2026. Its roughly 30% incremental-margin comment applied to North America, not to all future consolidated sales. The annual loss excluding refunds and the higher break-even threshold limit extrapolation from Q3. [S4]

Management reports large-ag share gains exceeding 200 basis points. These are management estimates, not an independently audited market-share census. Stable inventory coverage below seven months alongside higher shipments supports retail traction, but coverage uses forward demand assumptions. Actual units, cancellations, warranty costs and dealer incentives must confirm the claim. [S4]

PTx and the limits of an open architecture

PTx’s three routes are retrofit, factory-fit on AGCO machines and other-OEM relationships. Retrofit expands the customer universe and can offer a smaller investment when a farmer postpones replacement. Factory-fit improves technology attachment but follows machinery production. Other-OEM sales broaden distribution while depending on partners’ output and incentives. Calling all three countercyclical would overstate the protection.

A broader addressable fleet is not automatically a stronger moat. Compatibility, product efficacy, installation quality and service must remain differentiated. Openness can reduce the barriers a customer faces in adopting PTx while also reducing exclusive control over that customer. The financial outcome could be attractive distribution economics, ordinary component economics, or something between them.

At the October technology event, management acknowledged that attractive gross margins coexist with a large selling and research cost base and unsatisfactory operating margins. That is a stronger economic qualification than product demonstrations or dealer counts. No standalone, fully allocated PTx return on original acquisition capital is disclosed. [S19]

There is no demonstrated AGCO data-network effect to capitalize. More connected machines can help development and service, but public evidence does not establish how each incremental customer improves others’ outcomes or how AGCO captures that benefit. The same caution applies to assuming a competitor’s network effect merely from installed scale.

Verdict: The best-supported advantages are parts resilience, European differentiation and improving North American execution. They are real but bounded by geography, fixed costs and distribution economics. PTx adds strategic relevance; its capital-inclusive competitive return remains unproven.

Growth History and Forward Opportunities

The product outlook is strongest in replacement parts, selective premium-machine gains and precision upgrades with demonstrable farmer payback; broad equipment demand remains constrained by farm profitability and affordability. Growth must therefore be separated into market recovery, shipment normalization, share, pricing and technology adoption rather than assigned one secular rate. [S3][S4][S19]

Sales rose from $11.138 billion in 2021 to $14.412 billion in 2023, then fell to $11.662 billion in 2024 and $10.082 billion in 2025. The latest 2026 guide is $9.8–10.0 billion. Acquisition and disposal changed the perimeter, and the upcycle included substantial pricing. Neither peak-to-trough contraction nor longer-run growth represents pure volume or organic performance. [S1][S8][S9][S10]

The most immediate opportunity is reducing underproduction. A manufacturer shipping below retail depresses both revenue and factory absorption. Returning shipments toward retail can increase reported sales before end demand grows. It is a finite normalization benefit, however: once wholesale and retail are aligned, growth again depends on retail demand, share, price or content. It cannot support indefinitely high incrementals.

The regional balance differs. EME inventories are below the four-month target, creating some restocking potential. North America is below seven months against six, suggesting progress but not complete normalization. Latin America is just under five months against three, and management expects underproduction there during at least part of 2027. A single global restocking percentage would conceal the region that still needs contraction. [S4]

Latin America’s coverage increase from roughly 3.5 months in June came almost entirely from a lower forward retail forecast; management said physical inventory units increased only modestly. This is an important causal distinction. Coverage can deteriorate sharply without an equivalent shipment glut, but the weaker denominator still forces lower production to protect the channel. The necessary response is to reconcile units and expected demand separately, rather than interpreting a ratio as a physical inventory count. [S4] (p. 3)

North American early orders provide directional evidence rather than an aggregate growth forecast. A 20% increase covering 20–25% of regional sales contributes roughly four to five percentage points to regional growth if the rest is unchanged, before mix, cancellations and timing. The seasonal products covered have declined more sharply than tractors. Management explicitly warned that their rebound magnitude may not transfer to the larger tractor business. [S4]

PTx’s $2 billion 2029 objective requires approximately 30–32% annual growth over three years from a roughly $0.86–0.90 billion base. Growth could come from channel expansion, new products, industry recovery, retrofit penetration and higher content. The calculation identifies the burden of execution; it is not an independently supported forecast. The base valuation does not require full achievement of that target. [S5][S19]

Monetization is deliberately mixed. Management discussed modest annual charges for data tools, usage economics for autonomy and one-time purchases for some hardware. Farmers’ resistance to paying repeatedly for a second spraying pass illustrates why recurring pricing must fit customer value. A successful mixed model can create good returns, but its entire revenue base cannot receive a software subscription multiple. [S19]

Cost actions offer another bridge. Approximately $40 million of 2027 savings carryover would equal roughly $0.41 per share after an assumed 30% tax rate and a near-69-million denominator. Steel, freight, wages, tariffs, compensation and implementation costs can offset that benefit. Protecting development through the trough preserves future capability while increasing the current revenue threshold needed to earn acceptable margins. [S4]

The crucial distinction is between relevance and capture. Targeted spraying, seed placement and automation may improve farmer economics without generating proportionate supplier returns if competitors match functions, distribution is costly or adoption requires discounts. Useful commercial evidence would include paid installations, retained customers, revenue per dealer, warranty experience and incremental contribution.

Verdict: Production normalization and North American share gains provide measurable recovery mechanisms. PTx offers additional upside, but the required acceleration and conversion into profit are substantial. Fleet aging creates replacement need, not a date-certain purchase order.

Financial Quality

Earnings are near a cyclical low, with reported net income additionally distorted by transactions, taxes, impairments and restructuring. Neither the 2023 peak nor the 2025 headline EPS represents a reliable sustainable run rate. The most decision-useful assessment combines filed operating performance, issuer reconciliations and explicit economic sensitivities.

Five-year operating and cash record

Amounts are millions of dollars except EPS and margins. Simple free cash flow means operating cash flow less purchases of property, plant and equipment.

Metric 2021 2022 2023 2024 2025
Revenue 11,138.3 12,651.4 14,412.4 11,661.9 10,082.0
Gross margin 23.1% 23.7% 26.2% 24.9% 25.5%
GAAP operating income 1,001.4 1,265.4 1,700.4 (122.1) 595.7
GAAP operating margin 9.0% 10.0% 11.8% (1.0)% 5.9%
Net income attributable to AGCO 897.0 889.6 1,171.4 (424.8) 726.5
Diluted EPS 11.85 11.87 15.63 (5.69) 9.75
Operating cash flow 660.2 838.2 1,103.1 689.9 988.1
Capital expenditure 269.8 388.3 518.1 393.3 247.9
Simple free cash flow 390.4 449.9 585.0 296.6 740.2
Engineering expense 405.8 444.2 548.8 493.0 487.7

The series reconciles to the annual filings. It includes the historical portfolio rather than a fully reconstructed constant-perimeter company. Gross-margin resilience is favorable, but cannot isolate pricing power from parts mix, currencies and disposals. Factory absorption sits in production economics and cost of goods sold as well as affecting the ultimate operating result; the entire margin decline cannot simply be attributed to corporate fixed costs below gross profit. [S1][S7][S8][S9][S10]

GAAP beside adjusted earnings

Measure 2023 2024 2025
GAAP operating income $1,700.4M $(122.1)M $595.7M
Issuer-adjusted operating income $1,732.3M $1,043.3M $781.0M
GAAP diluted EPS $15.63 $(5.69) $9.75
Issuer-adjusted EPS $15.55 $7.50 $5.28

The adjustments run in both directions. The 2024 loss included $369.5 million of impairment, $172.7 million of restructuring and business optimization, and a $507.3 million G&P disposal loss. The 2025 operating bridge adds $82.2 million of restructuring, $60.7 million of PTx acquired-intangible amortization, $21.6 million of transaction costs, $10.0 million of impairment and $10.8 million of disposal loss. These totals replace narrower, inconsistent historical subtotals. [S6][S25]

For 2025 net income, the issuer removes $219.2 million after tax from the TAFE gain and $261.8 million of discrete tax benefits, approximately $6.44 per share together. Those were real events, but not recurring equipment earnings. Conversely, repeatedly excluding restructuring or acquired-technology amortization can overstate ongoing economics. Reporting the reconciliation transparently is evidence of disclosure quality; the accounting volatility does not establish concealed or fictitious earnings. [S25]

Company Financials’ standardized operating-income field differs materially from filed GAAP: its 2024 margin is approximately 7.95%, while the filing reports an operating loss. Its research-labelled field also equals total engineering expense, not the narrower disclosed R&D expense. Filed classifications control this analysis. Data normalization is useful for screening but cannot silently determine operating quality. [S13][S1]

Latest quarter and refund normalization

Metric Q3 2026 Q3 2025 Nine months 2026 Nine months 2025
Sales 2,262.5 2,476.3 7,215.1 7,161.8
GAAP operating income 116.1 151.6 337.5 365.0
Adjusted operating income 137.0 185.0 416.0 485.9
Adjusted operating margin 6.1% 7.5% 5.8% 6.8%
GAAP EPS 0.75 4.09 2.59 8.45
Adjusted EPS 1.05 1.35 3.42 3.11

Nine-month reported sales rose 0.7% but declined 2.7% excluding currency. Adjusted operating income fell 14.4% while adjusted EPS rose. Fewer shares and nonoperating developments therefore matter to the apparent recovery. Removing $13 million of Q3 refunds produces approximately $124 million of adjusted operating income and a 5.5% margin. Removing $35 million year to date produces $381 million and 5.3%. These are analyst sensitivities, not issuer measures. [S2][S3][S4]

Recoveries offset actual earlier tariff costs, so excluding them is not a complete multiyear tariff analysis. Their purpose here is to test repeatability. Similarly, the $20 million finance-stake-sale benefit recognizes estimated future runoff earnings upfront. A model should not retain the accelerated benefit while assuming the former affiliate earnings stream continues unchanged. [S2][S30]

EME earned $656.5 million through September, versus losses of $61.7 million in North America and $55.3 million in Latin America; APA earned $39.2 million. Total segment income of $578.7 million reconciles to $337.5 million consolidated operating income after corporate costs, amortization, stock compensation, restructuring and impairment. Segment margins cannot be compared directly with a consolidated peer margin without those costs. [S2] (Note 19)

Capital and ROIC

Balance-sheet item December 2023 December 2024 December 2025 September 2026
Cash and equivalents 595.5 612.7 861.8 415.1
Receivables 1,605.3 1,267.4 1,079.4 1,231.1
Inventory 3,440.7 2,731.3 2,709.3 3,005.0
Net property, plant and equipment 1,920.9 1,818.6 1,996.2 1,931.0
Funded borrowings, net of issuance costs 1,392.2 2,648.5 2,440.8 2,676.8
Common equity 4,656.7 3,742.8 4,273.5 4,065.2
Redeemable minority interest — 300.1 299.2 290.4
Goodwill 1,333.4 1,820.4 1,898.8 1,881.1
Year-end/period-end common shares, millions 74.518 74.421 72.629 68.951

The balance sheet shows acquisition-funded leverage, subsequent capital releases and renewed seasonal cash absorption. Property, plant and equipment is shown separately from operating right-of-use assets, avoiding the broader standardized-data grouping. Common equity excludes the separately presented redeemable claim. [S1][S2][S8]

For a reproducible operating-return measure, invested capital equals common equity plus minority capital plus funded borrowings, less cash and affiliate investments. Goodwill and recognized intangibles remain; operating leases are excluded. Average beginning/end capital and a 25% normalized operating tax rate are used. Removing affiliate capital matches operating income, which excludes affiliate earnings.

Average 2025 capital is approximately $5.55 billion. Defined GAAP ROIC is 8.0%; issuer-adjusted ROIC is 10.6%. The corresponding peak GAAP return in 2023 was approximately 28%, and 2024’s GAAP return was negative. These are analyst conventions, not compensation RONA or standardized service ratios. The important finding is wide cyclicality and an uncertain current excess-return spread. [S1][S7][S8]

A matched research sensitivity uses disclosed R&D of $420.9 million, $381.3 million and $374.5 million for 2023–2025, rather than engineering expense. With a two-year straight-line life and amortization beginning after the spending year, average added 2025 capital is $578.5 million. Replacing current R&D with cohort amortization reduces adjusted operating income by $26.6 million. The defined adjusted return falls to 9.2%. The useful life is an assumption, not an established machinery-development life. [S1] (accounting policies)

This estimate still uses issuer exclusions. Retaining acquired-technology amortization, recurring restructuring or original impaired capital would lower selected return sensitivities further. Simply adding expensed research to capital without adjusting profit is also wrong. Impairment reduced PTx’s recorded capital shortly after purchase, so improving future book returns will not necessarily recover the original cash commitment.

Cash conversion, obligations and accounting judgment

Net income is diverging from operating cash flow because working capital, deferred taxes and transaction items have different timing and classifications. Nine-month consolidated net income was $177.2 million, versus $183.9 million attributable to AGCO after minority losses. Operating cash flow was negative $218.4 million. Receivables consumed $181.3 million, inventory $302.4 million and accrued expenses $225.3 million; capex of $162.2 million produced negative $380.6 million of simple free cash flow. [S2]

The 2025 $740.2 million free-cash-flow result included substantial receivable and inventory releases. It is not sustainable solely because net income was positive. Nor is the seasonal nine-month outflow itself an annual run rate. At $5.50 guided adjusted EPS and an assumed 70.5 million annual weighted shares, adjusted common earnings would be about $388 million. Conversion of 75–100% implies approximately $291–388 million of full-year free cash flow; overcoming the nine-month deficit then requires roughly $671–768 million in Q4. This analyst bridge must be judged through actual collections, inventory units and supplier payments. [S2][S4]

Capital intensity includes factories, working capital and sustained development. Capex of $247.9 million in 2025 was near $256.5 million depreciation, but that does not establish maintenance investment. Earlier capex was higher, project timing varies, and expensed engineering is a separate resource commitment. Lower capex can conserve cash while leaving future catch-up needs.

Material economic obligations include redeemable minority capital, leases, pensions, dealer inventory-repurchase requirements and guarantees. The Argentine finance guarantee was $86.1 million. North American residual-value guarantees had a $12.9 million accrual but a $242.9 million maximum potential payment, which is a materially different risk measure. Neither maximum exposure nor an accounting accrual should automatically be added in full to funded debt. [S2] (Note 15)

Approximately $1.7 billion of sold wholesale receivables and another $239.2 million under other factoring arrangements remained outstanding. The specified wholesale sales are without recourse, so the balance is not hidden borrowing mechanically equivalent to debt. Dependence on those markets still affects liquidity. Supplier-finance balances of $52.1 million are already included in accounts payable. [S2]

Accounting conservatism is mixed: research is expensed and inventory reserves are material, while acquisition values, tax assets, warranties and recurring adjustments require judgment. Inventory obsolescence reserves rose from $271.9 million to $303.8 million. Deferred tax assets reached $1.002 billion. Warranty liabilities include extended-warranty deferred revenue, so they are not a pure expected-claims reserve. These balances require separate realizability and cost tests rather than a blanket conservative or aggressive label. [S1][S2]

Verdict: AGCO retains positive operating capacity, but sustainable returns are less exceptional than peak ROIC or 2025 cash flow suggest. Current earnings quality is understandable once reconciled; cash execution and acquisition-inclusive returns remain the principal financial tests.

Capital Allocation

AGCO’s allocation record must be judged across acquisition price, organic investment, financing disposals, share retirement, dividends and dilution. A lower share count does not by itself prove value creation, and a strategic disposal can improve future focus while crystallizing a poor historical return.

Free cash flow was $740.2 million in 2025 but negative $380.6 million through September 2026. Management describes priorities as balance-sheet capacity, business investment, selected technology opportunities and excess-capital returns. Current distributions have consequently relied partly on prior cash, asset monetization and borrowing rather than current-period free cash flow. That can be rational during a seasonal trough, but requires a successful cash release rather than automatic extrapolation. [S1][S2][S4]

PTx and portfolio returns

PTx Trimble’s final disclosed purchase consideration was $1.910 billion, including working-capital and other adjustments. Recognized assets included $1.592 billion of goodwill and $624.6 million of identifiable intangibles, alongside initially valued redeemable minority capital of $355.1 million. The minority is not additional cash AGCO paid at closing; it is another owner’s claim within the consolidated enterprise. [S1] (Note 3)

AGCO recorded a $351 million PTx Trimble North America goodwill impairment in 2024, within the acquisition year. That is direct evidence that initial expectations deteriorated quickly, with the filing identifying weaker demand and market penetration. It does not prove all future technology returns will be poor, but the acquisition verdict starts with lost expected value rather than an untouched strategic option. [S7]

The October 2025 impairment test disclosed 16% headroom in PTx North America, falling to approximately 3% with a one-percentage-point higher discount rate. Those are historical model sensitivities after the earlier write-down. They are not a current appraisal, nor evidence that all consolidated goodwill could disappear through one reporting-unit charge. The annual testing date is October 1; a September balance sheet does not settle the 2026 annual outcome. [S1][S2]

Trimble’s put and AGCO’s call first become exercisable April 1, 2027, with pricing based on EBITDA multiples subject to the agreement. The September carrying amount of $290.4 million is neither a guaranteed settlement price nor a conventional fixed-date debt maturity. Any buyout analysis must match the cash cost with the additional earnings acquired. [S1][S2]

G&P’s disposal improved focus but generated a $507.3 million 2024 accounting loss. Reported disposal cash proceeds were approximately $631 million that year. A sensible exit can coexist with disappointing lifetime capital returns; removing revenue from the denominator also makes subsequent margin comparisons look better without proving equivalent organic improvement. [S1][S7]

Repurchases, funding and dilution

The finance-JV sale released $188.4 million, comprising $168.4 million of carrying value and $20 million of estimated runoff earnings. The quarterly filing explicitly identifies the proceeds as a source of repurchase funding. That transaction exchanges future finance ownership economics for current capital and a smaller share count. It is successful only if the retired equity or other capital use provides an adequate return. [S2][S30]

Repurchase tranche Consideration Shares Approximate price
November 2025 ASRs, final settlement February 2026 $250.0M 2.331M $107.25
May 2026 ASR, final settlement July $293.0M 2.591M $113.08
TAFE, May 2026 settlement $52.1M 0.423M $123.3
TAFE, August 2026 settlement $56.8M 0.492M $115.33

The prices correct the earlier suggestion that first-half repurchases were uniformly near $100. Comparing them with today’s quote is an execution check, not a complete investment-return calculation. The relevant alternative is debt reduction, liquidity or another capital use, evaluated against future common-equity cash generation. [S2] (Note 10 and Item 2)

Common shares declined from 72.629 million at December 2025 to 68.951 million at September 2026, a 5.1% reduction. Some 2026 deliveries settled repurchases funded in 2025. Employee issuance partly offset retirement, and the remaining $383.1 million authorization is discretionary. The recent decline is not a sustainable annual repurchase rate by definition. [S2]

TAFE did not exit AGCO when AGCO sold its investment in TAFE. The cooperation agreement allows TAFE to maintain its ownership percentage and participate pro rata in repurchases. Large shareholder sales under that arrangement must be separated from discretionary executive selling and do not prove that an overhang disappeared. [S2][S31]

Stock compensation was $46.4 million in 2023, $18.4 million in 2024 and $28.4 million in 2025, rising to $34.6 million through September 2026. Gross employee issuance is more than offset by repurchases, so net dilution is currently limited; compensation remains an economic cost. A valuation cannot add back the expense while also assuming costless dilution offset. [S1][S2]

Dividends, insiders and governance

The regular dividend increased from $0.29 to $0.30 quarterly in April 2026. Annualized $1.20 payments imply roughly $83 million at the present share count and a 1.1% yield. Guided full-year cash generation would cover that several times, but year-to-date free cash flow did not. Special dividends of earlier years mean the regular payout alone understates historical total capital returns. [S1][S2]

Bob De Lange’s August 14 purchase of 1,000 shares at $100.71 was a verified code-P open-market transaction. September filings show Hansotia exercising 9,750 rights, withholding 7,146 shares and selling 2,604 shares; the three movements approximately offset in share count. Kelvin Bennett separately sold 1,000 shares. These are distinct categories, not one net conviction signal. A sale code alone does not establish a Rule 10b5-1 plan, and no plan-based motive is assumed for these trades. The reviewed filings do not establish an exhaustive five-year transaction census or prove the absence of other activity. [S20][S21][S22]

Annual incentives weight adjusted operating margin and RONA at 40% each, with customer satisfaction and engagement at 10% each. Long-term awards are approximately 60% performance shares and 40% RSUs. Performance shares weight revenue growth and RONA equally, with a relative TSR modifier of plus or minus 20%. [S6]

Non-employee directors received a $135,000 annual base retainer and $185,000 in restricted stock for 2025, with additional committee and lead-director fees. Ownership requirements are six times salary for the CEO, three times for other executive officers and five times the annual retainer for non-employee directors, subject to transition provisions. These requirements support alignment but are not independent evidence that a particular investment decision creates value. [S6] (pp. 23, 51)

The realized outcomes complicate an exclusively favorable assessment. The 2023–2025 performance cycle paid 23.9% of target, but the 2025 annual plan paid 163%. Industry-based target adjustment and additional exclusions for TAFE litigation and newly implemented North American tariffs supported the annual outcome. The proxy gives more information about the sliding-scale mechanism than the earlier report acknowledged. [S6]

Management’s incentives and behavior favor technology, premium products, asset efficiency and per-share returns, but do not establish acquisition or repurchase price discipline. Compensation RONA includes recorded goodwill and intangibles, yet differs from after-tax average-capital ROIC and cannot restore capital already impaired.

Verdict: Share retirement and return-oriented metrics are positives. The acquisition impairment, above-current-price repurchase tranches, annual bonus adjustments and future minority options keep the allocation record mixed.

Changes and Headwinds — Last Two Years

Results are driven primarily by external farm economics and the production cycle, while internal portfolio choices, cost control, service execution and capital allocation determine how much pressure reaches shareholders. An entirely macro explanation overlooks the acquisition and funding decisions; an entirely execution-based explanation ignores farmers’ ability to defer equipment purchases. [S1][S2]

Development Verified change Investment significance
2024 portfolio transformation PTx Trimble acquired; majority G&P business sold More technology exposure, integration costs and acquisition capital
2024 valuation reset $351M PTx North America impairment Initial expectations deteriorated within the acquisition year
2025 TAFE agreements Investment sale, dispute settlement, IP and cooperation arrangements Cash released and specified disputes resolved; continuing ownership retained
April 2026 finance sale U.S./Canadian stakes sold; commercial arrangements retained Ownership income changed; capital released for repurchases
January 2026 segment realignment Mexico moved into Latin America Historical regional comparisons require recasts
August 2026 leadership Agarwal became CFO; Audia moved to PTx and strategy Accountability changed before the prior report
October 2026 organization Executive team reduced; Dehner left his role Simplification with transition costs and execution risk
July and October guidance Sales and operating expectations reduced Demand and recovery remained weaker than planned

The transaction and leadership facts come from filings, rather than assumptions about unchanged management or financing ownership. [S1][S2][S18][S24][S31]

The business environment changed materially through weaker farm profitability, constrained financing, regional weather effects and trade uncertainty. Europe’s drought-related pressure and Brazilian credit conditions have become more important while North America improved relative to a weak market. USDA’s September forecast supersedes the prior U.S. figures, but U.S. aggregate farm income cannot substitute for regional customer economics. [S3][S14][S17]

July management commentary expected subsidized Brazilian funding to support the second half. October commentary was much less constructive: management described unusually slow uptake of the relevant funding program and a sharp downward revision to forward retail expectations. Those are company observations, not a verified national credit census, but their deterioration directly contradicts carrying July’s optimism forward unchanged. [S5][S4]

The latest guide implies a demanding seasonal profit bridge. At $9.9 billion sales and a 7% adjusted margin, annual operating income would be approximately $693 million. After $416 million through September, Q4 needs about $277 million on $2.685 billion of sales, or a 10.3% margin. Europe’s return from extended summer shutdowns, North American momentum and savings support the bridge. Latin American weakness and weaker pricing assumptions challenge it. [S3][S4]

The updated plan also reduces 2026 capex to $250–300 million and assumes 1.5–2% pricing, approximately 1% favorable currency, engineering near 5% of sales and a 31–33% tax rate. These are management assumptions. Lower investment helps the cash bridge, while weaker price realization or a higher cash-tax burden could offset part of that benefit. Engineering’s protected position explains why physical capex alone understates reinvestment. [S4] (pp. 7–8)

Tariff policy creates both direct costs and uncertainty for customers. The company recognized $35 million of refunds through September, with further recoveries excluded from guidance. Disclosures retain review and legal uncertainty, including potential repayment. The relevant economic question is the net cost across periods and future sourcing, not treating refunds as perpetual earnings or definitively free optionality. [S2][S3]

The TAFE settlement resolved specified disputes while transferring Massey Ferguson brand ownership in India, Nepal and Bhutan under protective arrangements and preserving a substantial shareholder relationship. It therefore changed commercial rights and governance rather than merely removing an adversary. Litigation resolution reduces one risk while requiring careful interpretation of ongoing agreements. [S6][S31]

Important management changes occurred in August and October while Hansotia remained CEO. Audia’s move places an experienced finance executive over the most contested strategic investment; it is not proof of future returns. The new CFO’s responsibility for both financial and accounting oversight makes reconciliations, cash execution and disclosure especially important tests. [S18][S24]

Facilities developments include a signed humanoid-robot pilot agreement at Hesston, Kansas, announced October 20 and expected to begin in 2027. Initial tasks include parts sorting, stacking and tote placement. This is a planned pilot, not a demonstrated production deployment. No quantified savings, investment return or material earnings benefit is assigned without operating evidence. [S32]

No material change in core revenue-recognition or research-expensing policy was identified in the reviewed current filings. Segment realignment and comparative reclassifications affect presentation; prospective expense-disaggregation requirements concern disclosure rather than an established change in economic results. [S1][S2]

Verdict: Strategic focus improved, but the latest demand deterioration and ownership changes increase the burden of proof on cash and technology returns. Internal cost progress is valuable and insufficient by itself to offset a prolonged external downturn.

Risk Analysis

The principal downside is delayed recovery combined with inadequate normalized margins and a valuation already dependent on improvement. Weak demand, underproduction, dealer caution and cash absorption can reinforce one another. The matrix separates observed conditions from judgments about likelihood and severity.

Risk Likelihood Impact Evidence basis Mitigation or offset Monitoring signal
Europe remains weak Medium-high High Q3 sales down 19.1%; margin 10.5% Lean channel and parts demand Orders, cancellations, pricing and recovery margins
Brazil demand and credit worsen High near term High Weaker outlook and coverage near five months Underproduction and eventual replacement Physical inventory, credit uptake and incentives
North American rebound stalls Medium High Near-zero Q3 profit excluding refund; YTD losses Share gains and product/service development Repeated ex-refund profit and warranty costs
Q4 cash release misses Medium-high High Negative $380.6M nine-month FCF Seasonal collections and inventory plan Receivables, inventory, supplier payments and net debt
PTx return disappointment Medium High Early impairment; uncertain standalone contribution Wider distribution and new products Annual test, revenue and capital-inclusive contribution
Redemption and refinancing compete for cash Medium Medium-high Minority options from 2027; 2027–2028 debt Revolver and potential operating cash Exercise terms, maturities and liquidity
Tariff burden or refund reversal Medium Medium-high Cross-border production and reviewed recoveries Sourcing and pricing Retained refunds and forward net costs
Warranty or price competition offsets share Medium Medium-high Premium warranty proposition; regional discounts Product differentiation and service Claims, reserves, net price and dealer profitability
Currency, tax or geopolitical shock Medium Medium-high International earnings and tax-asset exposure Local production and hedging FX bridge, cash taxes and realizability
Technology adoption without monetization Medium High over time Ambitious growth objective without return bridge Farmer productivity proposition Paid cohorts, retention and operating leverage

Likelihood and impact are analyst judgments, not statistical probabilities. Premises are supported principally by the latest filing and call, with acquisition and tax exposure documented in the annual filing. [S1][S2][S4][S7]

Stock-decline factors include another operating downgrade, weaker European pricing, Latin American credit stress, failed cash conversion, further PTx impairment and compression of the multiple applied to future earnings. A substantial share-price loss does not require insolvency. A profitable manufacturer can disappoint because normalized earnings arrive later, require more capital or receive a lower valuation.

The nearest risk is cash execution. The full-year conversion objective implies approximately $671–768 million of Q4 free cash flow. This is plausible given seasonality, but material relative to liquidity. A miss financed by additional borrowing while distributions continue would weaken both valuation and management’s claim that only excess capital is being returned. [S2][S4]

A catastrophic investment loss could result from simultaneous regional weakness, persistent working-capital absorption, dealer or financing disruption and more expensive refinancing. The equity has operating leverage before the financial leverage is considered. A technology impairment is noncash, but can reveal a deterioration in the future earnings expected to support debt, reinvestment and terminal value.

A total loss is not the central scenario; the plausible path requires prolonged operating and cash losses, erosion of finance and dealer support, exhausted liquidity and restructuring that leaves little for common holders. Positive operating income, parts demand and committed borrowing capacity argue against that path today. Its probability cannot be responsibly quantified from the reviewed public evidence. [S2]

The September balance sheet provides time rather than immunity: approximately $415 million cash and $996 million undrawn committed revolver capacity, with net funded debt of $2.262 billion. The company reported covenant compliance and repaid about $58.9 million of term debt in October. That repayment reduces cash and debt together; it does not automatically reduce net debt. [S2]

Refinancing risk is dateable. The $400 million 2027 notes, December 2027 revolver maturity and €600 million 2028 notes require planning. A 0.8% coupon on the euro notes is unlikely to represent a permanent funding cost. The actual refinancing spread and currency remain unknown, so a specific future coupon is not assumed. The minority options are a separate, contingent use of resources.

There is also risk to a bearish position. Retail stabilization plus production normalization can create rapid profit improvement, particularly with lean European inventories and a lower share count. PTx could earn significant incremental contribution on an established cost base. Demanding simultaneous confirmation from every annual measure can mean reacting after the stock has moved.

Verdict: Financial distress is not the base case, but severe equity losses are plausible through earnings delay and multiple compression. Cash, regional profit, physical channel inventory and acquisition assumptions offer more useful warnings than a reassuring headline leverage ratio.

Valuation Discussion

Valuation separates current earnings, recovery earnings, enterprise claims and the time required to reach a sustainable outcome. High trough P/E can coexist with attractive recovery economics, while a low multiple of distant earnings can still imply an inadequate present return. The scenarios below are assumptions, not price targets.

Equity and enterprise claims

At $110.91 and 68.950835 million shares outstanding on October 26, market capitalization is approximately $7.647 billion. September funded debt net of issuance costs was $2.6768 billion, against $415.1 million cash. The enterprise bridge includes redeemable minority capital because consolidated operating profit includes the venture’s underlying operations. [S2][S13]

Component Approximate value
Common-equity value $7,647M
Funded net debt $2,262M
Redeemable minority claim $290M
Enterprise value $10,199M
Less affiliate investments at carrying value $(497)M
Manufacturing-oriented EV sensitivity $9,702M

Affiliate book value is a proxy rather than an appraisal. Operating leases are excluded from this convention; a lease-inclusive analysis must adjust both valuation and earnings consistently. Pensions and guarantees remain relevant to equity cash flow even where not added mechanically. Adding the minority claim in EV and deducting minority earnings in a separate common-equity P/E scenario are consistent treatments, not a reason to subtract the claim again from the P/E result.

Current multiples and a corrected EBITDA bridge

Metric Approximate result Denominator
Price/guided adjusted EPS 20.2x $5.50
Market value/trailing common net income 27.4x $279.4M
Price/trailing adjusted EPS bridge 19.8x $5.59, approximate quarterly bridge
Enterprise value/guided sales 1.03x $9.9B midpoint
Manufacturing EV/guided sales 0.98x Same sales
Enterprise value/matched trailing adjusted EBITDA 10.3x $989.9M
Manufacturing EV/matched trailing adjusted EBITDA 9.8x Same matched earnings
Guided simple-FCF yield 3.8–5.1% Approximately $291–388M
Price/common book equity 1.88x $4.065B

The earnings and cash inputs reconcile to filings and issuer releases; prices come from Company Financials. Quarter-summed EPS uses changing share denominators, so it is approximate. The trailing common-net-income multiple uses current market capitalization divided by $726.5M minus $631.0M plus $183.9M, avoiding a misleading claim that the EPS sum is an exact trailing-year denominator. [S1][S2][S3][S25][S13]

The corrected trailing EBITDA calculation is explicit. Adjusted operating income is $781.0M minus $485.9M plus $416.0M, or $711.1M. Trailing depreciation and amortization total $336.3M. PTx amortization already excluded from adjusted operating income is $57.5M. Adding only the remaining $278.8M produces $989.9M. Removing the $35M recognized refunds yields $954.9M and increases EV/EBITDA to approximately 10.7 times. These are analyst calculations, not a company-defined EBITDA measure. [S2][S3][S25]

The full-year guide implies $693M adjusted operating income. Using trailing matched depreciation and residual amortization as a proxy produces approximately $972M of adjusted EBITDA, rather than approximately $1.02B obtained by adding all amortization again. Full-year D&A is not guided here, so this is a sensitivity. Funded net debt would be about 2.3 times that denominator.

Removing the $35M refunds and $20M finance-runoff benefit from guided earnings, at an assumed 32% tax rate and 70.5M weighted shares, reduces EPS by approximately $0.53. The roughly $4.97 sensitivity carries a multiple above 22 times. This is not a substitute forecast: recoveries offset actual earlier costs and finance ownership has changed. It reveals the difference between adjusted and repeatable earnings.

Peer and own-history context

Deere and CNH are justified peers by product competition, not merely sector taxonomy. At their October 30 prices of $675.48 and $11.76, Deere’s $4.75–5.00B net-income guide and approximately 270M diluted shares imply roughly 36–38 times earnings; CNH’s $0.41–0.46 adjusted-EPS guide implies 26–29 times. AGCO trades at a discount, but different finance contributions, geography, product mix, recoveries and perceived earnings floors explain part of it. [S13][S16][S17]

Deere’s PPA margin is higher, while CNH’s agricultural margin is lower than AGCO’s consolidated adjusted margin. Deere’s reported Q3 included $110M of tariff recoveries, with $382M recognized year to date; using a different quarter’s recovery would distort the comparison. CNH’s latest available release remains Q2, with Q3 scheduled for November 9. These period differences matter more than a superficially precise peer average. [S16][S17][S27]

Own-history percentiles have not been independently reconstructed. A transparent year-end price/sales cross-check is approximately 0.78x in 2021, 0.82x in 2022, 0.63x in 2023, 0.60x in 2024 and 0.75x in 2025. Current market value is approximately 0.75x trailing sales. These five observations are not a valuation distribution; they indicate that today’s sales multiple is not exceptional within this recent cycle. Portfolio changes and margins limit comparability. [S1][S8][S9][S10][S13]

Explicit 2029 operating scenarios

Assumption Bear Base Bull
Revenue $10.3B $11.8B $13.0B
Operating margin 7.5% 10.5% 12.5%
Operating income $773M $1,239M $1,625M
Net interest expense $125M $95M $75M
Other recurring pretax costs $70M $60M $50M
Tax rate 32% 30% 27%
Affiliate net income, after tax $25M $30M $40M
Minority earnings deduction $0M $20M $35M
Common net income $418M $769M $1,100M
Diluted shares 70.0M 68.5M 67.0M
EPS $5.97 $11.22 $16.42
Terminal P/E 10x 12x 13x
Terminal equity value/share $60 $135 $213
Present value at 10%, including ordinary dividends $48 $104 $163
Three-year annualized total return from $110.91 About (17)% About 8% About 25%

These margins include ongoing development and ordinary operating costs. The scenarios assume no major additional acquisition and no minority buyout; continued minority ownership is reflected in the earnings deductions. A buyout would require a separate funding and ownership bridge. The approximate three-year convention and $1.20 annual dividends make the time-value calculation reproducible.

Bear revenue is only modestly above the current guide, with inadequate regional profitability and little technology operating leverage. Base revenue recovers approximately 19% from $9.9B, while margin reaches 10.5%, below the 2023 GAAP peak. Bull margin exceeds that peak and therefore requires structural improvement, not just mechanical mean reversion. The terminal multiples are analyst assumptions, deliberately different across outcomes.

Reinvestment is explicit. Physical capex is assumed around $260M, $330M and $390M respectively, while engineering remains expensed in margins. Incremental working capital of 15% of the sales increase requires roughly $60M, $285M and $465M cumulatively relative to the $9.9B base. Share counts allow modest dilution in the bear and limited net retirement in the base and bull; the recent ASR pace is not extrapolated.

Embedded expectations and fragility

At a 12x normalized multiple, $110.91 corresponds to $9.24 of immediately sustainable EPS. Requiring a 10% annual return over three years, after $3.60 undiscounted dividends, raises required terminal EPS to approximately $12.00. That exceeds the base estimate. The market need not assume the full PTx ambition, but it must capitalize meaningful recovery with an adequate exit valuation.

One percentage point of margin on $11.8B changes pretax profit by $118M, approximately $1.21 per share at a 30% tax rate and 68.5M shares. At 12x, that changes terminal value by about $14.5 per share, before discounting. A one-year delay reduces a fixed future value by about 9% at a 10% hurdle. Timing and margin dominate small improvements in the share denominator.

A cash-flow cross-check reaches the same issue. At an assumed 11% cost of equity and 2.5% perpetual growth, approximately $650M of immediately sustainable next-year common-equity cash flow supports the current market capitalization. A future $650M outcome reached only after several years supports less today unless transition cash flows compensate. This is an illustrative reverse capitalization, not a second value to add to the scenario.

Verdict: AGCO’s peer discount is observable, but does not establish mispricing. The valuation depends chiefly on the margin, capital and time required for recovery; corrected EBITDA and minority treatment remove some apparent cheapness.

Variant Perception

The thoughtful investor questions in the latest calls concern the durability of North American profits, Europe’s seasonal recovery, Brazilian inventory and credit, the conversion of early orders, and PTx’s ability to turn adoption into contribution. Cash funding and the higher North American break-even threshold connect these questions to shareholder returns. They are more informative than a generic debate about whether agricultural demand eventually recovers. [S4][S5][S19]

Consensus and the strongest opposing cases

A current sell-side consensus forecast has not been independently reconstructed. Consensus here means expectations implied by the share price and public debate, not an observed mean analyst estimate. Approximately 20 times guided adjusted EPS and the positive response to reduced guidance are consistent with investors looking through current weakness. They cannot establish exactly which year, margin or PTx outcome the marginal investor expects. [S3][S13]

The strongest bull case begins with operating mechanics. Europe’s channel is lean, production normalization can lift absorption without strong retail growth, and North America demonstrated substantial incremental profit beyond refunds. Parts are resilient, development capability has been maintained, and fewer shares will participate in a recovery. None requires treating all PTx revenue as software or assuming another commodity boom.

PTx adds potential operating leverage. A farmer postponing a whole-machine purchase may still accept an upgrade with a short payback. New functionality can increase an existing hardware system’s value, while other-OEM relationships widen distribution. The financial test is whether revenue growth covers the large selling and research base and earns a return on the original resources committed, not whether demonstrations receive positive feedback. [S19]

The strongest bear case is that the inventory cycle improves while end demand and economic returns remain inadequate. North America’s annual ex-refund loss has not improved, Latin America’s forward retail assumptions deteriorated, and Europe remains the largest profit exposure. Capital returns have occurred during cash consumption. The technology objective requires rapid growth from an asset with an early impairment, while the current price already anticipates recovery. [S2][S4][S7]

The bull is falsified by sustained cash absorption, weak recovery incrementals, continued North American annual losses near its stated break-even scale, or PTx growth without contribution. The bear is falsified by repeatable regional profit, production normalization without inventory inflation, cash-funded distributions alongside declining debt, and technology returns that exceed a reasonable capital hurdle.

Five assumptions carry the debate: European differentiation survives the downturn; North American share gains become adequate annual profit; Latin American inventory clears without broad discounting; PTx monetizes its distribution and development; and normalized earnings arrive soon enough to compensate for waiting. These are operating and cash propositions, not conclusions available from price momentum.

Positioning and the factor model

The October 30 factor model estimates Market exposure of 1.124, Growth of negative 0.593, SmallSize of 0.465, Industrials of 0.517, Materials of 0.434, Financials of negative 0.382 and Quality of 0.124. Momentum is negative 0.065. R-squared is 0.379 and adjusted R-squared 0.368. Residual momentum is approximately negative 0.010; residual volatility is 0.2777 in the supplied convention, whose annualization is not independently established here. [S23]

These are statistical return diagnostics, not fundamental evidence. Sector exposures do not classify AGCO’s operations or establish causal commodity sensitivity. Negative Growth exposure does not forecast declining sales. Near-zero Momentum cannot establish crowding, short interest, marginal-seller exhaustion or a low positioning risk.

Approximately 62% of sample variance is unexplained by the included factors, but that remainder includes omitted common drivers and estimation error as well as company-specific effects. No current factor-return series, estimation window or coefficient standard errors were supplied, so the model cannot establish a favorable regime or the statistical significance of individual differences. The older snapshot is not used to infer a trend across potentially different specifications.

Verdict: The differentiated question is the quality and timing of recovery, not whether recovery is possible. Parts and North American execution challenge permanent impairment; cash, European concentration and technology capital keep the optimistic case conditional.

Fact vs. Interpretation

Reported facts, issuer adjustments, management claims and analyst estimates answer different questions. An accurately reproduced management statement remains a hypothesis about the underlying economics.

Proposition Classification Evidence and limitation
Q3 sales were $2,262.5M and GAAP operating income $116.1M Reported fact Filed statements. [S2]
Q3 adjusted operating income was $137M Issuer non-GAAP measure Reconciled adjustments. [S3]
North American Q3 profit excluding refunds was about $0.8M Analyst calculation $13.8M less $13M; not an issuer measure. [S2][S4]
North American nine-month loss excluding refunds was $96.7M Analyst calculation Reported loss plus $35M recoveries. [S2][S4]
Industry operates at 83% of mid-cycle Management estimate Does not entitle AGCO to revenue divided by 0.83. [S4]
Early orders imply 20% consolidated growth Rejected extrapolation Limited regional and product coverage. [S4]
Parts contributed 18.6% of 2025 sales Reported data and arithmetic Maintenance is resilient, not contractually recurring. [S1]
PTx will reach $2B in 2029 Management objective Requires a major growth acceleration. [S19]
PTx North America had 16% goodwill headroom Historical valuation estimate October 2025, after an earlier impairment. [S1][S7]
Redeemable minority capital was $290.4M Reported fact Separate from earnings allocation and eventual option price. [S2]
Defined 2025 adjusted ROIC is 10.6%, or 9.2% with research capital Analyst estimate Explicit tax, capital and useful-life conventions. [S1]
Matched trailing adjusted EBITDA is $989.9M Analyst calculation Avoids duplicating PTx amortization. [S2][S3][S25]
The annual incentive paid 163% while the completed long-term cycle paid 23.9% Reported compensation outcomes Different periods, targets and exclusions. [S6]
Zero momentum proves the shares are uncrowded Rejected inference Return exposure does not measure ownership. [S23]
Base 2029 EPS is $11.22 Assumption-driven estimate Revenue, margin, taxes, claims and timing dominate.
TAFE exited AGCO Falsified prior assertion Continuing ownership rights and pro-rata participation. [S2][S31]

Several cross-company analytical rules were retested. Separating captive finance remains essential for Deere and CNH, but AGCO’s equity-method structure and stake sales require a different implementation. Research capitalization requires matching both profit and capital; its magnitude cannot be imported from software, semiconductor or biotechnology companies. Immediately expensed acquired research is not the accounting mechanism of PTx, whose recognized acquisition assets require their own treatment. [S1][S16][S17]

Earnings can diverge from book equity through comprehensive income, but bank securities-mark mechanisms should not be transferred mechanically. AGCO’s accumulated other comprehensive loss is dominated by translation and pension-related components. Likewise, earnings/sales multiple divergence prompts reconciliation; it does not establish that sales multiples are intrinsically correct. [S1][S2]

Verdict: The strongest conclusions remain useful after their status is made explicit. Unsupported causal and valuation shortcuts are removed rather than given equal weight with filed evidence.

Open Questions

What is PTx earning on original capital? Purchase consideration and impairment history are known, but public disclosure does not provide a fully allocated standalone operating, working-capital and cash-return bridge. Revenue alone cannot settle the acquisition verdict. Consistent supplemental profit and capital disclosure would be more valuable than another adoption milestone. [S1][S19]

Can cash conversion be delivered without weakening the channel? The retained annual objective requires approximately $670–770 million of Q4 free cash flow. Collections and inventory reduction should be distinguished from delayed supplier payments, additional receivable sales or new asset disposals. A strong quarter that leaves dealers overstocked would be a weaker result than the same cash generated through genuine retail sell-through. [S2][S4]

Is North American improvement durable at adequate annual scale? Q3 proves meaningful operating leverage, while the annual ex-refund result remains negative. The $2.2–2.3 billion break-even estimate is management’s current threshold, not a guaranteed profitable revenue level. Tariffs, warranty costs, price and channel investment can move it. [S4]

What is the current goodwill cushion? The 16% figure belongs to October 2025. Absence of a September impairment does not disclose the October 2026 annual test. Updated growth, discount-rate and reporting-unit assumptions are needed; a historical sensitivity should not be treated as a present valuation. [S1][S2]

How will the minority options affect cash? The carrying amount is observable, but exercise, ultimate consideration and timing remain uncertain. A buyout may improve common earnings while consuming cash or adding interest expense. Continued minority ownership and funded acquisition must be modeled as distinct alternatives. [S1][S2]

What tax rate should be normalized? Management expects 31–33% for 2026, while the base scenario uses 30%. Geography, loss utilization, incentives and discrete items explain why a return to a low historical effective rate is not automatic. Realization of tax assets may affect cash independently of the reported provision. [S1][S4]

How much technology revenue is recurring and profitable? Warranty obligations are not software ARR. Paid subscriptions, renewals, usage and incremental contribution are insufficiently disclosed to value the entire PTx base as recurring revenue. Hardware, installation and dealer support can absorb value even when customer productivity improves. [S1][S19]

How strong is the insider signal? The specific purchase and sales reviewed here are verified. A refreshed comprehensive transaction census was not established, so conclusions about the absence of selling or relative sector leadership are unwarranted. The thesis does not depend on attributing one director’s purchase to superior private foresight. [S20][S21][S22]

Verdict: The most valuable missing evidence concerns capital-inclusive technology returns and sustainable cash conversion. Those gaps justify scenario dispersion, not a more precise unsupported central forecast.

What Must Be True

Bull tests

The bullish recovery mechanism requires production normalization, retained differentiation and cash contribution. The observed starting points are lean European inventories, North American quarterly break-even excluding refunds, weak Latin American forward retail and negative nine-month free cash flow. The thresholds below are analyst monitoring rules, not company guidance. [S2][S4]

Required condition Measurable confirmation Falsifier Monitoring period
North American gains become economic profit Two consecutive positive quarters excluding recoveries, followed by annual profitability Annual loss persists as sales approach $2.2–2.3B, or shipments require increasing physical dealer stocks Q4 2026 through 2027
Europe retains differentiation Margin recovers with production and stable net pricing Margin stays below roughly 12% across recovering-volume periods because of price, warranty or cost deterioration First two meaningful recovery quarters
Cash supports the balance sheet Annual FCF reaches 75–100% conversion objective without asset-sale dependence Material conversion miss, then continued cash absorption and debt-funded distributions FY2026 and first-half 2027
Latin American inventory normalizes Coverage moves toward three months with stable or improving forward retail Coverage remains near five months or worsens while discounts broaden Through 2027
PTx translates relevance into return Revenue growth and disclosed operating contribution improve together Another recovery year with flat sales, weak contribution or impairment without a credible return bridge 2027 results and annual tests
Recovery incrementals are adequate Consolidated operating improvement supports roughly 20–25% incrementals after identified one-offs Two recovery quarters below 20% without a persuasive temporary cause 2027–2028

The regional targets, conversion objective and North American break-even reference come from the current call. PTx’s growth objective and constrained operating profitability come from the technology event. They establish premises for testing, not evidence that the thresholds will be achieved. [S4][S19]

North America’s literal positive-quarter test has been met; its annual economic-profit test remains open. Europe’s 10.5% Q3 margin does not by itself fail the recovery-period pricing test because sales and production declined. Latin America’s coverage deterioration supports caution, but the physical-unit and forward-demand components must be separated. [S2][S4]

Bear tests

Bear proposition Supporting evidence What would falsify it
The trough extends without enough earnings recovery Lower guidance and weak external retail Sustained retail improvement and firm orders, with production normalizing without inventory inflation
North America remains structurally inadequate YTD loss, almost-zero ex-refund quarterly profit and higher break-even scale Several profitable ex-refund quarters, an adequate annual margin and stable warranty economics
Europe cannot support the required return Q3 compression and profit concentration Recovery margins at stable pricing, with sound collections and aftermarket performance
PTx destroys additional capital Early impairment and limited standalone return evidence Capital-inclusive returns above an explicit hurdle, supported by cash and repeatable contribution
Capital returns reduce flexibility Repurchases during cash outflow and finance-sale funding Post-reinvestment cash funds distributions while net debt falls and minority obligations remain covered
The market capitalizes too much recovery Current multiples depend on substantially higher future earnings Earnings and sustainable common cash flow exceed the base without disproportionate capital or dilution

The bear premises are supported by the latest filing, retail evidence and acquisition disclosures. A further impairment would weaken the return case but would not automatically determine the common-equity value; conversely, absence of impairment would not prove that acquisition returns exceed the cost of capital. [S2][S3][S7][S15]

Monitoring should connect retail units, actual inventory units, forward demand assumptions, price, warranty claims, segment profit excluding recoveries, cash collections and net debt after distributions. Dealer coverage alone can improve because forecasts rise, just as it can worsen because forecasts fall. EPS can improve because shares decline while operating income falls. Both require a bridge.

Verdict: The case remains two-sided and falsifiable. The next decisive evidence is repeatable profit and cash, assessed against the regional and financing premises documented in the Q3 filing and the Q3 earnings call. [S2][S4]

Public source appendix

  • S1: AGCO 2025 Form 10-K — primary_filing; published 2026-02-13; Items 1 and 7; consolidated statements pp. 49–53; accounting policies and R&D; acquisition Note 3 pp. 64–66; goodwill estimates pp. 43–44; affiliates, taxes, revenue Note 24 and segments Note 25.
  • S2: AGCO Q3 2026 Form 10-Q — primary_filing; published 2026-10-29; Cover share count; balance sheet p. 3; operations pp. 4–5; cash flows p. 7; receivable sales Note 2; debt Note 7; equity Note 10; commitments Note 15; affiliate sales; segment Note 19; MD&A pp. 35–46.
  • S3: AGCO Q3 2026 earnings release — primary_earnings_release; published 2026-10-29; Quarter and nine-month statements; regional results; industry estimates; 2026 outlook; GAAP/non-GAAP operating-income and EPS reconciliations.
  • S4: AGCO Q3 2026 earnings-call transcript — issuer_hosted_transcript; published 2026-10-29; 20-page issuer transcript: p. 3 production and inventory units versus forward retail; pp. 6–8 guidance, capex and conversion; pp. 9–18 Q&A on orders, regional profitability, Brazil, costs and break-even.
  • S5: AGCO Q2 2026 earnings-call transcript — issuer_hosted_transcript; published 2026-07-30; 19-page issuer transcript: pp. 4–9 inventory, parts, finance-stake sale, capital returns and July guidance; pp. 17–19 PTx revenue and channels.
  • S6: AGCO 2026 proxy statement — primary_proxy; published 2026-03-12; Director compensation p. 23; compensation discussion pp. 26–51; annual incentive metrics and 163% payout pp. 39–45; performance shares and 23.9% payout pp. 46–49; ownership requirements; TAFE arrangements pp. 79–80; RONA reconciliation.
  • S7: AGCO 2024 Form 10-K — primary_filing; published 2025-02-24; Consolidated statements and cash flows; goodwill estimates pp. 43–44 and accounting policy pp. 58–59; $351M PTx North America impairment; acquisition and G&P disposal notes.
  • S8: AGCO 2023 Form 10-K — primary_filing; published 2024-02-27; Consolidated income statements, balance sheets and cash flows; engineering and research expenditure; segments, affiliate investments and share count.
  • S9: AGCO 2022 Form 10-K — primary_filing; published 2023-03-01; 2020–2022 consolidated statements; operating review, engineering, debt, cash flow, equity and capital expenditure.
  • S10: AGCO 2021 Form 10-K — primary_filing; published 2022-02-25; Consolidated statements and MD&A; 2021 revenue, operating income, engineering, cash flow, capital expenditure and equity.
  • S13: Company Financials — profile, statements, ratios, valuation, prices and calls — third_party_financial_data; publication date unavailable; Primary symbol resolved to NYSE:AGCO; annual 2021–2025 statements and profitability; quarterly enterprise value and valuation; 1,255 unadjusted daily price rows November 1, 2021–October 30, 2026; NYSE:DE and NYSE:CNH October 30 closes; Q3 and Q2 2026 calls cross-checked against issuer transcripts. Material financial classifications reconciled to filings.
  • S14: USDA ERS September 2026 farm-income forecast — government_forecast; published 2026-09-03; September 3 update: 2026 net farm income $158.4B; nominal and real change; net cash income $176.4B; direct government payments $47.4B. Forecast, not realized income.
  • S15: AEM September 2026 tractor and combine sales — industry_primary_data; published 2026-10-19; September U.S. tractor and combine year-over-year changes; U.S. and Canadian market definitions.
  • S16: Deere Q3 fiscal 2026 earnings release — peer_primary_release; published 2026-08-20; Segment results pp. 5–7; Q3 $110M and nine-month $382M tariff recoveries; net-income and industry outlook; finance and diluted share-count data.
  • S17: CNH Q2 2026 earnings release — peer_primary_release; published 2026-08-03; Agriculture adjusted EBIT and margin; financial-services past dues and South America commentary; industrial cash-flow and adjusted-EPS outlook.
  • S18: AGCO August 2026 leadership-change Form 8-K — primary_event_filing; published 2026-08-03; Item 5.02: Indira Agarwal CFO appointment and Damon Audia’s move to PTx and corporate strategy, effective August 1.
  • S19: AGCO October 2026 Technology Event transcript — issuer_hosted_event_transcript; published 2026-10-06; PTx channels and $2B 2029 objective pp. 18–22; subscription, usage and hardware monetization pp. 22–25; operating-margin and selling/research-cost discussion p. 27.
  • S20: Bob De Lange August 2026 Form 4 — primary_insider_filing; published 2026-08-17; Table I and footnote 1: August 14 code-P open-market purchase of 1,000 shares at weighted-average $100.71.
  • S21: Eric Hansotia September 2026 Form 4 — primary_insider_filing; published 2026-09-08; Tables I–II: September 4 exercise of 9,750 rights; withholding of 7,146 shares; sale of 2,604 shares.
  • S22: Kelvin Bennett September 2026 Form 4 — primary_insider_filing; published 2026-09-08; Table I: September 4 code-S sale of 1,000 shares at $132.89.
  • S23: the factor model — October 30, 2026 snapshot — quantitative_diagnostic; published 2026-10-30; Supplied dated exposures and diagnostics: R-squared 0.379218; adjusted R-squared 0.368342; residual momentum -0.0101553; residual volatility 0.277717. Estimation window, standard errors and annualization not independently established.
  • S24: AGCO October 2026 executive-restructuring Form 8-K — primary_event_filing; published 2026-10-05; Item 5.02: executive-team reduction and Torsten Dehner transition.
  • S25: AGCO fourth-quarter and full-year 2025 results — primary_earnings_release; published 2026-02-05; 2025 statements and cash flows; GAAP/non-GAAP reconciliation, including $219.2M after-tax TAFE gain, $261.8M discrete tax benefits, acquired amortization and prior-year comparisons.
  • S27: CNH announcement of Q3 2026 reporting date — peer_primary_announcement; published 2026-10-19; October 19 announcement scheduling Q3 results for November 9, 2026.
  • S30: AGCO Q2 2026 Form 10-Q — primary_filing; published 2026-07-30; Statements, debt, repurchases and affiliate-investment disclosures; April sale of North American finance-JV stakes for $188.4M including $20M of estimated runoff earnings.
  • S31: AGCO July 2025 TAFE settlement Form 8-K — primary_event_filing; published 2025-07-01; Item 1.01: settlement, investment sale, intellectual-property and cooperation agreements; continuing ownership rights and pro-rata repurchase participation.
  • S32: AGCO and Agility Robotics announce Hesston humanoid-robot pilot — primary_company_release; published 2026-10-20; Signed pilot agreement; planned 2027 start; parts sorting, stacking and tote-placement tasks; no demonstrated savings assumed.